Page 3 - Gregor Siebert News Today

Investegate announcements from PAION AG, PAION IS HOSTING A SPONSORED ANGIOTENSIN II SYMPOSIUM AT ISICEM IN BRUSSELS

EQS-Ad-hoc: PAION AG / Key word(s): Miscellaneous PAION receives positive CHMP opinion recommending approval of remimazolam for the induc...

PAION AG / Key word(s): MiscellaneousPAION receives positive CHMP opinion recommending approval of remimazolam for the induction and maintenance of general anesthesia in adults27-Jan-2023 / 12:59 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS...

EQS-News: PAION AG / Key word(s): AGM/EGMPAION AG: Extraordinary General Meeting approves capital reductions and creates scope for further corporate financing 25.01.2023 / 17:35 CET/CESTThe issuer is solely responsible for the content of this announcement.PAION AG: Extraordinary General Meeting approves capital redu...

EQS-News: PAION AG / Key word(s): AGM/EGM PAION AG: Extraordinary General Meeting approves capital reductions and creates scope for f...

Investegate announcements from PAION AG, Extraordinary General Meeting approves capital reductions and creates scope for further corporate financing

Investegate announcements from PAION AG, ​​​​​​​PAION ANNOUNCES SUBMISSION OF NEW DRUG APPLICATION FOR REMIMAZOLAM BY ITS LICENSEE CRISTÁLIA IN BRASIL

EQS-News: PAION AG / Key word(s): Regulatory Admission PAION ANNOUNCES SUBMISSION OF NEW DRUG APPLICATION FOR REMIMAZOLAM BY ITS LICE...

EQS-News: PAION AG / Key word(s): Corporate ActionPAION AG issues statement on planned capital measure 16.12.2022 / 10:19 CET/CESTThe issuer is solely responsible for the content of this announcement.PAION AG issues statement on planned capital measureAachen (Germany), 16 December 2022 - PAION AG (ISIN DE000A0B65S3;...

EQS-News: PAION AG / Key word(s): Corporate Action PAION AG issues statement on planned capital measure 16.12.2022 / 10:19 CET...